Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.

Virzì S, Iusco D, Baratti D, Bonomi S, Grassi A, Kusamura S, Deraco M.

Tumori. 2013 Sep-Oct;99(5):589-95. doi: 10.1700/1377.15307.

PMID:
24362862
[PubMed - indexed for MEDLINE]
2.

Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.

Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virzì S, Leo E, Deraco M.

Dis Colon Rectum. 2014 Jul;57(7):858-68. doi: 10.1097/DCR.0000000000000149.

PMID:
24901687
[PubMed - indexed for MEDLINE]
3.

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.

Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I.

Trials. 2010 May 25;11:62. doi: 10.1186/1745-6215-11-62.

PMID:
20500867
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

Cashin PH, Graf W, Nygren P, Mahteme H.

Eur J Surg Oncol. 2012 Jun;38(6):509-15. doi: 10.1016/j.ejso.2012.03.001. Epub 2012 Apr 3.

PMID:
22475555
[PubMed - indexed for MEDLINE]
5.

[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].

Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.

Ann Ital Chir. 2008 Jul-Aug;79(4):231-9. Italian.

PMID:
19093624
[PubMed - indexed for MEDLINE]
6.

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.

Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoetmulder FA.

Eur J Cancer. 2001 May;37(8):979-84.

PMID:
11334722
[PubMed - indexed for MEDLINE]
7.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
[PubMed - indexed for MEDLINE]
8.

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study.

Deraco M, Rossi CR, Pennacchioli E, Guadagni S, Somers DC, Santoro N, Raspagliesi F, Kusamura S, Vaglini M.

Tumori. 2001 May-Jun;87(3):120-6.

PMID:
11504363
[PubMed - indexed for MEDLINE]
9.

Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases.

Schneebaum S, Arnold MW, Staubus A, Young DC, Dumond D, Martin EW Jr.

Ann Surg Oncol. 1996 Jan;3(1):44-50.

PMID:
8770301
[PubMed - indexed for MEDLINE]
10.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.

Teo MC, Tan GH, Tham CK, Lim C, Soo KC.

Ann Surg Oncol. 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0. Epub 2013 Mar 17.

PMID:
23504144
[PubMed - indexed for MEDLINE]
11.

Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.

Zani S, Papalezova K, Stinnett S, Tyler D, Hsu D, Blazer DG 3rd.

J Surg Oncol. 2013 Mar;107(4):307-11. doi: 10.1002/jso.23222. Epub 2012 Jul 18.

PMID:
22811275
[PubMed - indexed for MEDLINE]
12.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.

PMID:
22395983
[PubMed - indexed for MEDLINE]
13.

Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.

Cavaliere F, Di Filippo F, Botti C, Cosimelli M, Giannarelli D, Aloe L, Arcuri E, Aromatario C, Consolo S, Callopoli A, Laurenzi L, Tedesco M, Di Angelo P, Giunta S, Cavaliere R.

Eur J Surg Oncol. 2000 Aug;26(5):486-91.

PMID:
11016471
[PubMed - indexed for MEDLINE]
14.

Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis.

Elias D, Honoré C, Dumont F, Ducreux M, Boige V, Malka D, Burtin P, Dromain C, Goéré D.

Ann Surg. 2011 Aug;254(2):289-93. doi: 10.1097/SLA.0b013e31822638f6.

PMID:
21709543
[PubMed - indexed for MEDLINE]
15.

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.

Chua TC, Quinn LE, Zhao J, Morris DL.

J Surg Oncol. 2013 Aug;108(2):81-8. doi: 10.1002/jso.23356. Epub 2013 Jun 5.

PMID:
23737041
[PubMed - indexed for MEDLINE]
16.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.

Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, Koller M, Schlitt HJ, Piso P.

BMC Cancer. 2013 Feb 7;13:67. doi: 10.1186/1471-2407-13-67.

PMID:
23391248
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y.

Ann Surg Oncol. 2011 Jun;18(6):1575-81. doi: 10.1245/s10434-011-1631-5. Epub 2011 Mar 23.

PMID:
21431408
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI.

J Am Coll Surg. 2014 Apr;218(4):573-85. doi: 10.1016/j.jamcollsurg.2013.12.013. Epub 2013 Dec 21.

PMID:
24491244
[PubMed - indexed for MEDLINE]
19.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
[PubMed - indexed for MEDLINE]
20.

[Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].

Virzi S, Iusco D, Grassi A, Navarra G, Ismail I, Panetta A, Bonomi S.

Chir Ital. 2008 Nov-Dec;60(6):825-30. Italian.

PMID:
19256273
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk